Celgene (CELG) Tops Q4 EPS by 3c, FY Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Total costs and expenses: 2.57B
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Total costs and expenses: 2.57B
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Celgene (NASDAQ: CELG) reported Q4 EPS of $2.00, $0.03 better than the analyst estimate of $1.97. Revenue for the quarter came in at $3.48 billion versus the consensus estimate of $3.47 billion.
GUIDANCE:
Celgene sees FY2018 EPS of $8.70-$8.90, versus the consensus of $8.64. Celgene sees FY2018 revenue of $14.4-14.8 billion, versus the consensus of $14.82 billion.
For earnings history and earnings-related data on Celgene (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
- Marriott Vacations Worldwide (VAC) Tops Q3 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
